Name: | Description: | Size: | Format: | |
---|---|---|---|---|
541.46 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Head and neck cancer (HNC) patients who underwent percutaneous endoscopic gastrostomy (PEG)
present malnutrition risk and speech impairments. Their assessment relies on objective
anthropometric/laboratory data. Focusing on HNC PEG patients, our aims were to evaluate: 1)
outcome; 2) nutritional status when the patients underwent PEG; and 3) association of nutritional
status/outcome, creating a survival predictive model. We evaluated the outcome based on NRS
2002, dietary assessment, body mass index (BMI), mid-upper arm circumference (MUAC), triceps
skinfold thickness (TSF), mid-arm muscle circumference (MAMC), albumin, transferrin, and
cholesterol on the day of gastrostomy. Using BMI, TSF, MAMC, and laboratory data, a survival
predictive model was created. Of the 234 patients (cancer stages III–IV), 149 died, 33 were still PEGfed,
and 36 resumed oral intake (NRS-2002 3, caloric needs <50% in all). BMI was 12.7–43. 189,
197, and 168 patients displayed, respectively, low MUAC, TSF, and MAMC. 91, 155, and 119 patients
displayed low albumin, transferrin, and cholesterol. Albumin, cholesterol, and transferrin were
strongly associated with the outcome. A predictive model was created, discriminating between
short-term survivors (<4 months) and long-term survivors. HNC patients were malnourished. Using
anthropometric/laboratory parameters, a predictive model provides discrimination between
patients surviving PEG for <4 months and long-term survivors. Teams taking care of PEG patients
may provide special support to potential short-term survivors.
Description
This is an Accepted Manuscript of an article published by Taylor & Francis in Nutrition and Cancer on 2016, available online: http://www.tandfonline.com/10.1080/01635581.2016.1158297.
Keywords
Malnutrition Head and Neck Cancer PEG Percutaneous Endoscopic Gastrostomy
Citation
Jorge Fonseca, Carla Adriana Santos & José Brito (2016): Malnutrition and Clinical Outcome of 234 Head and Neck Cancer Patients who Underwent Percutaneous Endoscopic Gastrostomy, Nutrition and Cancer, DOI: 10.1080/01635581.2016.1158297
Publisher
Taylor & Francis